PARTNER Risk Model (TAVR) Calculator

Clinical calculation support · Verify results before clinical use

Patient parameters

Enter pre-procedural clinical variables. Use the units shown for each field.

Clinical model verification pending

Patient age at the time of assessment.

If reported in µmol/L, convert to mg/dL before entry.

Use the documented functional class before TAVR.

Convert from g/L when necessary.

Reset form
Model verification notice. The current source equation has not been verified as the original PARTNER model for 30-day mortality. This tool intentionally does not generate a numeric risk estimate until its coefficients and endpoint are confirmed.

Clinical context

Risk prediction after transcatheter aortic valve replacement depends on the specific model, its intended population, endpoint, predictor definitions, and validation cohort. A model developed for poor outcome at six months should not be relabelled as a 30-day mortality model.

The PARTNER trial established evidence for TAVR in patients with severe aortic stenosis who were at high surgical risk or considered inoperable. That trial citation alone does not establish the legacy five-variable equation shown in the previous calculator.

Input summary

VariableUnit / codingValidation range
AgeYears18–120
Serum creatininemg/dL0.1–30
NYHA class III/IVNo = 0; Yes = 10 or 1
Body mass indexkg/m²10–100
Serum albuming/dL0.1–10

References

Leon MB, Smith CR, Mack M, et al.

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363:1597–1607.

doi:10.1056/NEJMoa1008232

Primary PARTNER trial report; not verified as the source of the legacy five-variable equation.

Kapadia SR, Leon MB, Makkar RR, et al.

Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results from the PARTNER Trial. Circulation. 2015.

Read the open-access publication

This study evaluates a composite poor outcome, including death or poor quality of life, rather than validating the equation in the legacy file as a 30-day mortality model.

Pre-procedural risk models for patients undergoing transcatheter aortic valve implantation.

Review of TAVI-specific clinical prediction models and their endpoints.

Read the review
Clinical disclaimer: This page is an input-validation interface, not a validated risk calculator in its current state. Do not use it to estimate individual mortality risk, select treatment, or counsel patients about numerical prognosis until the model equation has been checked against its original publication and appropriately validated. Clinical decisions require the treating Heart Team's assessment.